N
Google TrendSOCIAL SECURITY 2027 COLA ANNOUNCEMENT (500+) — When will 2027’s Social Security COLA be announced?
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:social security 2027 cola announcement500+benfica vs vitória sc200+energy ceasefire200+elliot anderson200+r.c.d. mallorca - u. d. las palmas200+quinyon mitchell2000+tornado north carolina1000+sean young500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Precision BioSciences App" (30 stories)

Top Headline Story

A gene-editing approach to hepatitis B is set for a late-breaking talk
Lead StoryStock Titangeneral
3d ago

A gene-editing approach to hepatitis B is set for a late-breaking talk

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNNGhmX0V6cE9KUzV0ajFKN0wyQkNUMzJiX1lqN3J4TnY2NzFMbEtlNDhEaTE4eHhQSVR5SVA1eHFSVTFza2R4YWFWaWFnLU1KU2o1NFUweU05SHl6cGhUNWFoNzFXN3RzNDF3ektybXMyMFBXTkh0MFpwQS1hdVFjUEw2RWtuV1VYZlY2SXVlX0pVaUgxLVNXTlVBcHF2Qk5uU0treXdqbWREZGxQVE9McnB3R2ZxdG91cG4xNkdIdVo?oc=5" target="_blank">A gene-editing approach to hepatitis B is set for a late-breaking talk</a>  <font color="#6f6f6f">Stock Titan</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+20m ago

social security 2027 cola announcement

When will 2027’s Social Security COLA be announced?

Filter stories
200+30m ago

benfica vs vitória sc

Benfica tem 'roupa nova' para receber o V. Guimarães: o onze provável

Filter stories
200+30m ago

energy ceasefire

Trump announces partial ceasefire in Ukraine war as Zelenskyy says deal is ‘news to me’

Filter stories
200+30m ago

elliot anderson

James McAtee: How Oliver Glasner has transformed Nottingham Forest midfielder from forgotten man to his new Adam Wharton

Filter stories

Search Results for "Precision BioSciences App"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update
Lelezardscience

Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxQNkh4US1PX1cxNHlLdG9PdHlrRVB4MWtwdEJ2ZTRHazZQQ28zZUVLRlNoVjc2MjZKOFYtUzlnTmFQa29JUnF2RHpfSkZLNno3di14aFlCMFdLdlVCek9fdjMxNzk3bk9qdmtzN2M4Q2xUOEV6QnpuREpPYmF1UGlKN0lySm9Dc0V0WjhLdlpLeGV1VlVxdm83Y1RFXzkxdDF5Snlhak9BczRNT2cyTjBQMmRPbk5LVnFKaXRrcE1YWHUwVUNQZ3Rjd2g0VW9TLWU4bGJlR1hTNy1zQQ?oc=5" target="_blank">Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update</a>  <font color="#6f6f6f">Lelezard</font>

Read Full StoryMore like this
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries
Business Wirescience

Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries

<a href="https://news.google.com/rss/articles/CBMihwJBVV95cUxOYmJYelU1ekhoMHc3eTUwVjFrMjZ5cUEtOXYyRnJJOUZFOFAydHc2TDlfR2dxcEhzang1QWFEanZhS3l0QnVrOWt2Y3BHY1pmV2ZSVVU5SjA0MERLb2JsVVVkT2ZfcmY2cWE5czlPbHFTNEpXY3BFWGR6YXhPNXZDZTJ0dnJ4OTg2U0ZpZmdqbnN2blJNQzNmTHNSLWljMjRTb2hWN21oQWR1UXhXbFZhd1hHdUREMVVUeWh2LTRZX1J0MklGam5ucHUwQnJnazE3UUlTYmlUVFhpYnJxeXJTNzhqV3psZjJsd2RDU3ZGOUpWNkZ1VFg0VThodFRsVEo5LW5fcWlNZw?oc=5" target="_blank">Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Precision BioSciences doses first patient in Phase 1/2 FUNCTION-DMD gene-editing trial
Dealroomscience

Precision BioSciences doses first patient in Phase 1/2 FUNCTION-DMD gene-editing trial

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQQ0phcXVqLXV2RmdCNjVMVVl5RG1qY1VJbFZUVlI3a0R2aGl3WHNCTlRfN0V1WkJOZ1NLLV9sWWduY2hURkdmdUpqVnRJZTdMNWJCdVEzTjYwa1ZqMzhHaWpUYk9SbE9iTzlfRTdOVUFHMjBqRFl5ZHdHV2d6M25URDN3M0M0WUhQV1FJUTJpMkYwQU5sbXJmWlJqMVgtWHFMMWZWeUdYNS1KT1lOTjlVam5lMkNRbVhaSXlVWg?oc=5" target="_blank">Precision BioSciences doses first patient in Phase 1/2 FUNCTION-DMD gene-editing trial</a>  <font color="#6f6f6f">Dealroom</font>

Read Full StoryMore like this
Precision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional Investors
Yahoo Financemarkets

Precision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional Investors

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPNkptLU1Qd0p0cHZpUFZuTkFJVkxnVjhmTms2R0tQQlhQb0lFQmhTSnpPMzBQRUNWWWh4aWVoLTlDXzlHNEJnOGNlcmhHTDRncy1tZ0dBbzhvZ2JkcEtUakdzQjRhczcwVDVjNXJXUmhaSlE2RktTQ1VfS2RoNjNQTGJFbEl1SjA5Z3E0a2lWWjd2WFpiMURoaUhjTDNCdUZGMGhDZWE5cUhlX05EdGgwdEljNms?oc=5" target="_blank">Precision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional Investors</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences
European AIDS Treatment Groupscience

Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxNdUN4MllydUZkdHU2RmEtczNjLWhyX1dxMUFBdnJzNnZKSjZ2dkpMNnlabzF2NThjR1BoZktpVmNxQUc5Mm43U000SmZIVFVCbnNtSzRKejlkVDI0TjZNLU9WMFp3YXZ2Z2F1UGRZSkdBd0JtQ1hGeHRCSEs2SGZCeXhTN3hjV09fZFV4UkpaVnFwU2VXN24tY01Mdm5OZWduSllfMTFjaXBTb0p6endHM3NSdDhvQ0MwaHRnRnEtWmZWQXZKNHBNTEN3RQ?oc=5" target="_blank">Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences</a>  <font color="#6f6f6f">European AIDS Treatment Group</font>

Read Full StoryMore like this
Precision BioSciences (NASDAQ:DTIL) Passes Minervini Trend Template and High-Growth Momentum Screen
ChartMillscience

Precision BioSciences (NASDAQ:DTIL) Passes Minervini Trend Template and High-Growth Momentum Screen

<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxPb2twdE43ZVlORUZfQ1NOQU1jajNwSF9RQW9uc1M0Z21SeEdDQ1pIMjlCaXAyM0xJcE45VmhmZEp1czVmd3pfVnl6VXFGNG9BbVlSVzNNVDF1Q2hrTTk4WWpGMW1zWjVoRThYdHNYMjBzaHZpWjN5anlVUUZTaWNId3dvY1ZBQ3FXWUJWQ0J6TnlURFBkM1BPOXV2aWQ0T2swVnlqVHRVNENUcnVaV1FfZUFkdmFmX3VDTnc0bmZfenBWSzEyMlVtM0MxWFA5alJoRndYVFgxV2JJeXdFMWdzSlBn?oc=5" target="_blank">Precision BioSciences (NASDAQ:DTIL) Passes Minervini Trend Template and High-Growth Momentum Screen</a>  <font color="#6f6f6f">ChartMill</font>

Read Full StoryMore like this
Precision receives CTA approval to expand ELIMINATE-B study
Clinical Trials Arenageneral

Precision receives CTA approval to expand ELIMINATE-B study

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxQWFBZT1FWTFFtTHlPQ01CUlU4TUdTWkZ5ZmROUjdZWEdYSjRSb3gzYi1obHp1MlNvTGZqQnFPSk1FamlNNjVsU0k5TDFtUjVMYm1UV2hXLXpDWFB3cFBHYU1FcVBwd0JXc1Q1QXYzM0JjUGxQTmtEbW1DS3NiU2JiY09Yc3NRZkQ2Mnc?oc=5" target="_blank">Precision receives CTA approval to expand ELIMINATE-B study</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
Precision BioSciences (DTIL) Stock Faces Dilution Risk As Revenue Fades
Simply Wall Streetmarkets

Precision BioSciences (DTIL) Stock Faces Dilution Risk As Revenue Fades

<a href="https://news.google.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?oc=5" target="_blank">Precision BioSciences (DTIL) Stock Faces Dilution Risk As Revenue Fades</a>  <font color="#6f6f6f">Simply Wall Street</font>

Read Full StoryMore like this
C16 Biosciences Unveils Precision-Fermented Cocoa Butter & Expands Beauty Portfolio
Green Queen Mediascience

C16 Biosciences Unveils Precision-Fermented Cocoa Butter & Expands Beauty Portfolio

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxQT1lXWHVEYVdwX3lZLWF2QWhyUDEyZEdpMF96ajZWWmFLR0FmeDdDS2FoaWNnUUw2dzRjOW5qbktLVTh1NVNZVzZEdkRkeDZRTnllMTJtazQtcnFrMmUzdXNZNnhTRW5LZlBYTkw3OWtvWE1GT0FfN2JTU1RCUEppVEE5NmxfcWlmeHdMS24wcjRnakY1VWpTNWhrY0NmbnYtazNCaFZLdUZlczRudVE?oc=5" target="_blank">C16 Biosciences Unveils Precision-Fermented Cocoa Butter & Expands Beauty Portfolio</a>  <font color="#6f6f6f">Green Queen Media</font>

Read Full StoryMore like this
Precision BioSciences: Q2 Earnings Snapshot
Yahoo Financescience

Precision BioSciences: Q2 Earnings Snapshot

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOTmxJc3NlbGU0eHJFOE84UlZtWVdnT0YyQldpd09COHFlT0FQWG8teVM1bVg5eE1uUVd2ZUd4V09vaGNDS0Rkc2xqMHBmVWIwMlB2Ti1zY3R4bTJseE4wR0Zlc1B2WE9LNDN0REE1eGJ5Z2V3Q0dtdTYzOEJxQ05zQ0NURXNZa3prNW0yb19MQUVUMk0yQjU2TU9FVFNNMHBmR3FPbUlR?oc=5" target="_blank">Precision BioSciences: Q2 Earnings Snapshot</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026
Business Wirescience

Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026

<a href="https://news.google.com/rss/articles/CBMiqgJBVV95cUxQMHUtZUR0NW9acE95NlpCVHR4WlI3dVhRTGlYOHZOdzZIRWF2Y1VEYmZKcHgxVHZnemhiRHpTZC1XdFhWSEVmMEFqbjFESnNFanNkNmFVN3pPOFdRVm8zNENrZEFOYkJtU2xTUlJjdUs2MHhPWUZKNnc4d1NYY3lYU3M4V3pKWUNXXzN5TElKdmk3NzNwS3VTSWNLSGtNdURjRjJvcTFqeC1jdUZaYkRiLTJvcFM0eUVtYUdCQk5fOWotdWxScGVDTHVEU25ycnVjdi1KSG5CdXNLSWJpT0dudXlmbjBxLWJ2c0d3dlBwSnJUaERSX0tyeGlTSjZFTERKZmhaTlZPNUl5emJkRHZmYXY2MTVaRThKS2RBS3U1ZEo2cl9YZVg3Z2Vn?oc=5" target="_blank">Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Cogent Biosciences Announces FDA Acceptance of New Drug
GlobeNewswirescience

Cogent Biosciences Announces FDA Acceptance of New Drug

<a href="https://news.google.com/rss/articles/CBMivgJBVV95cUxNa0VCTmFwT1JOcXFaOVBiY2dQaTc0TU9xZVR6MXEwVmVOZGVRMTNOeXJRQ21Lb0pYSzhUSlNSUE1PNTd1bjAtZko0WC01XzdCLUp5Vno2Ulg4RURiTVZHT082TGJDcVdpbWtZQmJZekZoMDg4eVV1YnBTdm9NNGloOUlaOFVXbGR3UlI4YkxSejhKZzFIdy04SGJzb3RIcmdxdVpHaE84b0FNTFZoRGFtaVRFUjR3bE1NRXNiMTlPMTJrSUMxVTNWaDVWM0F4aGFkejVNV2IxOHdockE4WFQxLTN0bVFBbVplMWZ4b0dnN2tEUUpLOHB0dGNGd1lHa2F2RUx3OE9ZcGZpcVZDSmdzanRxaE56ZEFuZXdwMWVDY0U1TV9QT0gyQlNCR3o1THZ5Z0ljYVE1X1VzUW1WMWc?oc=5" target="_blank">Cogent Biosciences Announces FDA Acceptance of New Drug</a>  <font color="#6f6f6f">GlobeNewswire</font>

Read Full StoryMore like this
Precision BioSciences Inc. (DTIL) Shareholding Pattern – Promoters, FIIs & DIIs
Value Researchscience

Precision BioSciences Inc. (DTIL) Shareholding Pattern – Promoters, FIIs & DIIs

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOaXZSV2VOd2pRaEZFQnZNYTI2QnhnUUJqVElTdk02NVZHQmRUSnNnZGVGVmROdVhfNEp2amVJV3pkTkZmZ0JaQTVDcl85LS1pZWhMSzV4NmNXNXlqZVRDSHVVa2FqODJwQ0JCOUsxUmVubVZxRmQzYUNxdkFVN041ZFliOGdkVUVpOEg0OVYzVmJDbG5nVDFWdDhR?oc=5" target="_blank">Precision BioSciences Inc. (DTIL) Shareholding Pattern – Promoters, FIIs & DIIs</a>  <font color="#6f6f6f">Value Research</font>

Read Full StoryMore like this
Press Release Service: Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE
CRISPR Medicine Newsscience

Press Release Service: Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE

<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxNNjFJSFJjMjN3bElYc1pSenFQSElKM0t2TUFSQXNyQjZNTzlBWFRZVWtZSnB5TEVDWHBkem9pOVRTcE9NUVVRVEIxZ09fVUpYSV9SVVhPRlg3emNSaDc3akRvclJoem5XVGpKQ2YyTml2allZLS1qSnoxalBHQUNxRDNEN20wYk5FSy1EZ2JwRGZ4SVhzRno3cDhBUHdvNTl5QnhFM3M3X0x0R1kxTVIyM19FNUkxeE54cDRqQ2xMSm9wTHp5c1pHUFJLV0tBc01hb25ndEN1bXN2cFZmVFdZdmQ2OGNCck9aSXNZejQwaV8?oc=5" target="_blank">Press Release Service: Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE</a>  <font color="#6f6f6f">CRISPR Medicine News</font>

Read Full StoryMore like this
Precision BioSciences Announces Clearance of Investigational New Drug Application by the U.S. FDA for First-in-Class PBGENE-HBV Designed to Eliminate Root Cause of Chronic Hepatitis B
BioSpacescience

Precision BioSciences Announces Clearance of Investigational New Drug Application by the U.S. FDA for First-in-Class PBGENE-HBV Designed to Eliminate Root Cause of Chronic Hepatitis B

<a href="https://news.google.com/rss/articles/CBMixAJBVV95cUxORkVyREZTaEZlTFJ3UEhrXy1OZjdXMDhkZl9LeDdYTHFfbGtOQnN4NDRSMWViX3RVZlh4djNRQUMzeks5NS1IZWZHeG10ZTJFeFNVUVhNQVNlN0VlMVV4VjU4Q3o1ak4yYTcxSERNUW55VFpYSDZIM3RhendYZWlzdExmUmR4Q3F1R0NyYlBuYmE2ZlRFUmF4MVVzaGxZb010ZnZwQS1TRENQUWtXR1c0RGtGMExvSUtobG1PZlZpQ1pHWjBxT3BBTUUxNmxxX2ZpVjdfdVpXWTVTOWtjOUhObEM0S01yN21ZQjJjX2o4UEZCMUYwUWg4VE1Jd1ZzbEZxMU1xRV81R1lPcDctN2NITmZkX1FxTEg3TG1DMy13SV9IY0EyTTRzX3o0SGVSLWl6NmFJNWRoS0xJR3dqVTFpZl8yQ0E?oc=5" target="_blank">Precision BioSciences Announces Clearance of Investigational New Drug Application by the U.S. FDA for First-in-Class PBGENE-HBV Designed to Eliminate Root Cause of Chronic Hepatitis B</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?
Yahoo Financescience

Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQTDUtdnREV2FLd2pUZGFJWVBsT1FoLXVUZmFuMHA2OFJESTUyRGtpVEpVd0ZDbGUxVzlWaVhjTUpZMUxpeVJ5Ql9XUS1iTHZPWEl0bDZDMUlWMWhnWlZIdDJUQ2ZULUNQZ24xVHVPQVRRdXNiRFFkU2dRLXV1ZUxHc293VjZfbS1Kc2dGVGlGbmdtUjVRSUFWWTRlV285M2ZYV3BrUlVKM2Y?oc=5" target="_blank">Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy
Business Wirescience

Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy

<a href="https://news.google.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?oc=5" target="_blank">Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Financescience

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxOQTdLSG16SEtmcjRlOXB5UW1UNUZjem5QRmdNNnV4SFdTaHZzUkd3bDFlVy1jUTNQVC1Vc2tLckZ2b2hHQkZadHZzQ0EydmVtZEt6UC1VYzVha2lnbjNwZUY5SU9aU2JXanBLTGNjMzhPVzRTdDZObWtkSzBDOUJfYTJJZ3dHSF9GT3hBa0drUVJWNF9CZFNPMC1wbDhtdDFfWkFMY0NKekg?oc=5" target="_blank">Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study
Yahoo Financescience

Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNc3FDTW01RWNjSU5GUUpoMFZmaVplMENZUE9tUzZJa0oyajN0WG1QbVdMOGpPVEFGNUZVaGk1YmlCQUZ6MTBUUXFubnE4OFM4TnRCTVdfaExrTjI2c2tja0ViSjdWd3pVVnBJVmZyZFk5bHpLWWZVaGFsUmNLMm1lSWhXOFZ4dFV4eEZpUFhfMDQzWXExSGdHLWhJaEs1WXUyUzYwdTY5MXE?oc=5" target="_blank">Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
Precision BioSciences Appoints Michael Amoroso Chief Executive Officer
Precision BioSciencesscience

Precision BioSciences Appoints Michael Amoroso Chief Executive Officer

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxPS19TbmF3VWxIcTFuZ3hGd0xqR2FjWmNFOGJPdG1aNWlCQkc5QmdzX0VYN2p4VGNXTmtua0tmTEJOdVVWeVpCZ3phOUI5WkFfNFdBMFBuVnJ2ckNMbWMxWkZMY19IUEQ1MDNIYkZ2VlB1dm5JTFFRMnJCNTFSX2EyeFhYTnJRVlV0MHhMb2FmU19ZWkpTM3dRLTFDQ1BBcDN3amxRbWx3SVdJckJucU1LSGQzeGwyQi1kX0h4WDc1d2JjckZiY2puUmtoU1htOUFfVHhvbXE5Yw?oc=5" target="_blank">Precision BioSciences Appoints Michael Amoroso Chief Executive Officer</a>  <font color="#6f6f6f">Precision BioSciences</font>

Read Full StoryMore like this
Precision BioSciences (DTIL) Rises 1.78% as Gene-Editing Stock Holds Firm Above Support - Dividend ETF
dars.gov.etmarkets

Precision BioSciences (DTIL) Rises 1.78% as Gene-Editing Stock Holds Firm Above Support - Dividend ETF

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQUnBkc0h0TEVud0I5aFpXamFfX0FRcElLVjhhQzVQVDZ6WmxESjRTWFAwekFHTndYZGtMdkZzWUZjTEdSaENSSUpVamJxM0VzVUtaRVQtU0hla0RPbFJhQVZoazJWOGU1WXcyY1Z3RGtPYjdOaGc3X3BpeHFROW51RlRsb2R1R3BpbDczVWRvbFZIQVItSTU1S0lUZmtRdXZjZGl2T0tHdV9UQ21LYTRPcmNDVnl6anU3NEV5Z3VhcUE2WnNldWc?oc=5" target="_blank">Precision BioSciences (DTIL) Rises 1.78% as Gene-Editing Stock Holds Firm Above Support - Dividend ETF</a>  <font color="#6f6f6f">dars.gov.et</font>

Read Full StoryMore like this
Precision BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update
BioSpacescience

Precision BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxNaUU0aW41WldCNWZfUHk4d0dFMkxBVTluYldab0FQNUJIWk9uaWlubXdIRXFRc05sSDQxbzN5X2pyZ29KQ0U1U1hvR0hxQ3JMSFV2NC1rRUhkdmlETUdnRC1WS0VDRTVwX0FXckVvOWQ3THRaSnhXaGNSU2lJZUJRQUdHMzhBczB2S3BoV2ZWVE5QOGZ6MUxrT0NzY21tc0J6dk5VYnNUVjlpbjg5UjBRdS1od0plb05ma3ZfNnpBSVozd3dTQk0tejR4ZXJMLU9m?oc=5" target="_blank">Precision BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
CRISPR Medicine Newstech

Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics

<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxPSVU2akFpdXZUVGNDM0sybGlzUnU4SUpNamV1MlR0akh2VUR0TWtHS3p2RVpuTzdzbDNkcDEyR2dKaEZfUW90N0VuelpLOHlMQkQtVm9nZFd3ZVdKbkl6UFU2TzlBU3NxUHNVbnNDLXRaYjdGTlNWNlBiMERGMVY0S3FYZXNPVGZ0WHpsQl9wVDlFLTU3TnhJMDR0R3cxbDlSTE9iR1EwN3hpZzdONkhDQ3NOaEtOMVFiWENFRHhwdzZEd3VHRl9kUkxHbDFEckhrSUpOd1EydHRwSVZtUjhMMWRJZkRoUmRzdllWeU15Ulk?oc=5" target="_blank">Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics</a>  <font color="#6f6f6f">CRISPR Medicine News</font>

Read Full StoryMore like this
Precision BioSciences Announces Late-Breaking Poster Presentation at the 30th Annual International Congress of the World Muscle Society
BioSpacescience

Precision BioSciences Announces Late-Breaking Poster Presentation at the 30th Annual International Congress of the World Muscle Society

<a href="https://news.google.com/rss/articles/CBMihgJBVV95cUxNV3lqV2V5QWREVEF1Z09RckxZaUtkeTB6Tk1tb3g2Z0xUWVRZdVZBVVQ4OU5kXzc4Vm95ZHMtaTZqaTVDWFRzYmZtNkpsbkwybkU5bjk5SVRXcC1uR2Rvc1hmUzhHeDA2QUFFTWxyQWJvME9iNklHT1ZZN0ozVWY0RVhCUmpINEdGV0wxMVhRMzJIdGNRREpvTnppbXlsYmFMd1dVenBOX1FIb0dlclpSVld1M1JTTVdVR1RGSVg5ZjNHbDJvY2JCS1FBVFc2M0ZQSjlIcktyeFYwWWdBbV9IMmVvVW1uZVpMYkM3QUJrNzA2SkY0Q0I2YmZITkl2Y0ZXTHkwX3FR?oc=5" target="_blank">Precision BioSciences Announces Late-Breaking Poster Presentation at the 30th Annual International Congress of the World Muscle Society</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Precision BioSciences initiates PBGENE-HBV first-in-human study for the treatment of chronic hepatitis B in Moldova
European AIDS Treatment Groupscience

Precision BioSciences initiates PBGENE-HBV first-in-human study for the treatment of chronic hepatitis B in Moldova

<a href="https://news.google.com/rss/articles/CBMimwJBVV95cUxQc2d3bndxTEtHb0V5elpkdk1vUHBrN2ZOUTBTMmlkb3JiT3IzcDFfY1FGcmh1T2lvSnpHQ205VmVWbVNPVnRPWDVPb1lHRUpuRk1YVlc5by00al9ZQ0FHVHJJd1cteXpER2gyay04U25Kc2NHa2RTOUlHTzF4bkhMNm5GQ1BZT0FGalJfVkxoY2NaS3hLZUFXcnZRd0ZUQU9uSExZSFd6TFZUbEN0ajhKemRUWUNEQWd6bWppYU1HbzBHdmxJWEpPcmk0bjhhVEEwVmhYM3ZmZFY5SVM2aFktQ3JsUG5qVVZqVjhYSzFDWVk5RndtVGVaTEo0ZUdBdmlDc1hqdTlaaHJDTV94RjROZ0VONHNqcUxjYjBV?oc=5" target="_blank">Precision BioSciences initiates PBGENE-HBV first-in-human study for the treatment of chronic hepatitis B in Moldova</a>  <font color="#6f6f6f">European AIDS Treatment Group</font>

Read Full StoryMore like this
Unveiling ARCUS Gene Editing Platform and Its Potential in DMD: Cassandra Gorsuch, PhD
NeurologyLiveworld

Unveiling ARCUS Gene Editing Platform and Its Potential in DMD: Cassandra Gorsuch, PhD

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPMV84cE5EcEdmM0lTLUpKSFl4Nnk4TU03cnFJbmRTSjhyV0p3RkFOeHdaWEx1eUg0c2JmV0c0NVVMWEIyZzhXcTlvanJDTlBsbGFnUVlwNXJqNFhFdV9jSC1xS1oxTXVsc2xueE1tZ3JzRzFiV3ZIN2dpcXhrWWNEU3NxOUtlVXlVdXdsakxaUldvMkRkSmhhVGo4ckp0X0VmMk9KRUdMQQ?oc=5" target="_blank">Unveiling ARCUS Gene Editing Platform and Its Potential in DMD: Cassandra Gorsuch, PhD</a>  <font color="#6f6f6f">NeurologyLive</font>

Read Full StoryMore like this
Precision reports initial outcomes from Hepatitis B trial of PBGENE-HBV
Clinical Trials Arenageneral

Precision reports initial outcomes from Hepatitis B trial of PBGENE-HBV

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE5CMl8tVm1vZXNSZFhVUjljYUtweUVSQWZOTURKYm4wdThPeTdUdGdwNE9mTW1nMEJfZkdLeHJpMFdtc0RWWjhWSC1oSzZCY3hmblVRay1NRlNhZUhGanNTbHdWbGVPZ2daWjhENnNMLWJKcDFja2lJ?oc=5" target="_blank">Precision reports initial outcomes from Hepatitis B trial of PBGENE-HBV</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS
CRISPR Medicine Newsscience

Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS

<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxPc3k0NTRUaF82RXE1OUNlbkJlWjZtTmt6bkdaRXFXWUh3U0pIQWxFeDVqNjI0S0lqZllmLWRnMk9QTnR1V2hmNXVOVkVYamdacDBZejNvRWVXY1R5TWtCdVJwdlo5VWpFbE5hVk1KU2dGNFMxcUVpX0wzTnNZTmpjOVpybk1wTVhaTGs1Q3FfRlZlV1VWdFFibzV0elp4UFlCOTE5T3ZmcEM3ZjVYeUREaFJrdzJOZFg4YUlieDNsWTlnUk9fYi1waHZkRTVEdWFGLXdPOWgxQ0tnQ1ExY3BaMDVQQm50Y2N5bFdHcWQyT3A?oc=5" target="_blank">Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS</a>  <font color="#6f6f6f">CRISPR Medicine News</font>

Read Full StoryMore like this
Precision gains FDA approval to begin Phase I/II FUNCTION-DMD trial
Clinical Trials Arenatech

Precision gains FDA approval to begin Phase I/II FUNCTION-DMD trial

<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTE9tTFJTS2dsaG9fWFVleThsQlo3UXgwdEhqd2hQRmNYcWNIWHZwbFR5R1B3dWhWb0c0d3dqc0g3RktRZk04dk9SdjhNckVEb2hjTHBabi05Zk1DQVJfUVRLbTljY2RkbUFKbzNNLUVsRmhCTE4wZHhKTkZIbmVwT0E?oc=5" target="_blank">Precision gains FDA approval to begin Phase I/II FUNCTION-DMD trial</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
"Precision BioSciences App" — Live Google News Trends & Headlines